Faceclin AT Gel is a topical medication formulated with Adapalene 0.1% w/w and Clindamycin 1% w/w, designed to effectively treat acne vulgaris. Adapalene, a third-generation retinoid, works by modulating skin cell turnover and reducing inflammation, thereby preventing the formation of new acne lesions and promoting the healing of existing ones. Clindamycin, a lincosamide antibiotic, targets and inhibits the growth of acne-causing bacteria, particularly Propionibacterium acnes, reducing bacterial colonization and inflammation. The combination of these two active ingredients provides a dual-action approach, addressing both the inflammatory and bacterial components of acne, making Faceclin AT Gel suitable for patients with moderate to severe acne. The gel formulation ensures easy application and rapid absorption without leaving a greasy residue, making it convenient for daily use. It is recommended to apply a thin layer once daily, preferably in the evening, on clean, dry skin. Users may experience mild irritation, dryness, or redness initially, which typically subsides with continued use. Faceclin AT Gel should be used under medical supervision, avoiding contact with eyes, lips, and mucous membranes, and patients should use sunscreen during treatment to protect sensitive skin from UV exposure.